BioSpace News Archive

FDA

The U.S. Food and Drug Administration (FDA) Has Granted Orphan Drug Designation to PharmaMar’s Lurbinectedin

PharmaMar (MCE: PHM) announces that lurbinectedin has been granted orphan drug status by the FDA for the treatment of small cell lung cancer.

August 3, 2018
·
4 min read
Business

Birner Dental Management Services, Inc. Schedules Call To Discuss Six Month And Second Quarter 2018 Results

Birner Dental Management Services, Inc. will conduct a conference call to review six month and second quarter 2018 results.

August 3, 2018
·
1 min read
Biotech Beach

JenaValve Technology Initiates U.S. Patient Enrollment in Early Feasibility Study of Next-Generation TAVR System for the Treatment of Severe Aortic Stenosis and Severe Aortic Regurgitation

Successful Implantations Completed with Everdur™ Transcatheter Valve and Coronatix™ Transfemoral Delivery Catheter at Columbia University Medical Center and MedStar Washington Hospital

August 3, 2018
·
4 min read
Drug Development

Key Australian Patent for Recce’s Broad-Spectrum Antibiotics

Recce Pharmaceuticals Ltd (ASX:RCE) (Company), the Company developing a new class of broad spectrum synthetic antibiotics, today announced that Australian patent WO2016/077879 ‘Copolymer and Method for Treatment of Bacterial Infection’, has been accepted for grant by the Australian Patent Office.

August 3, 2018
·
2 min read
FDA

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps the agency is taking to support the development of novel nicotine replacement drug therapies to help smokers quit cigarettes

The development of novel NRT products, regulated as new drugs, is a critical part of the FDA’s overall strategy on nicotine.

August 3, 2018
·
6 min read
Policy

Information Update - Unauthorized workout and sexual enhancement supplements seized from “Edge Nutrition” in Windsor, ON, because they may pose serious health risks

Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

August 3, 2018
·
7 min read
Drug Development

bluebird bio to Present Updated Data for Lenti-D™ Gene Therapy for Cerebral Adrenoleukodystrophy at SSIEM 2018 Symposium

Data Include Updates from Phase 2/3 Starbeam (ALD-102) Study of Lenti-D for Cerebral Adrenoleukodystrophy (CALD) and Initial Data from Ongoing Observational Study (ALD-103) of Allogeneic Hematopoietic Stem Cell Transplant for CALD

August 3, 2018
·
7 min read
Drug Development

Calculus Capital invests £2m in Oxford BioTherapeutics

Calculus Capital, the award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist, has invested £2m in Oxford BioTherapeutics (OBT), a clinical-stage oncology company that is developing next-generation cancer treatments.

August 3, 2018
·
2 min read
Job Trends

AAFP Program of Excellence Awards Recognize 18 Family Medicine Interest Groups

The American Academy of Family Physicians named 18 medical school Family Medicine Interest Groups as the 2018 Program of Excellence Award winners for their exemplary efforts to grow and support interest in family medicine.

August 3, 2018
·
4 min read
Pharm Country

Creative Enzymes Provides Enzyme Activity Measurement for Alcohol Dehydrogenases

Creative Enzymes, a world leading enzyme products and services provider based in NY, USA, is pleased to provide a variety of enzyme activity assays, including enzyme activity measurement for alcohol dehydrogenases for customers all over the world.

August 3, 2018
·
1 min read